Shares of Beigene soared on Tuesday after scoring a cancer drug development deal with Novartis. The deal, announced at the annual J.P. Morgan Healthcare Conference, is worth up to $2.2 billion. Novartis will pay Beigene $650 million up front and make milestone payments to develop and sell its cancer drug, tislelizumab. Beigene will receive up … Continue reading “Beigene Inks $2.2 Billion Deal with Novartis”
Tag: novartis
Biotech & Pharma
Novartis Investigational Immuno-oncology Drug Fails Skin Cancer Trial
Swiss drug maker Novartis announced over the weeknd that the company's investigational spartalizumab immuno-oncology drug…
August 25, 2020
Novartis to Acquire Heart Drug Maker The Medicines Co
Swiss drugmaker Novartis announced this week that it is acquiring The Medicines Co in a…
November 26, 2019
Pharmacy Wants FDA of Chemical Causing Cancer in Blood Pressure Medication
Valisure has warned the Food and Drug Administration of a chemical that is believed to…
June 19, 2019
Biotech & Pharma
Novartis’ Gene Therapy Gets Nod from FDA
Shares of Novartis were climbing higher on Friday after the Food and Drug Administration (FDA)…
May 25, 2019
Biotech & Pharma
Novartis is Buying Endocyte for $2.1 Billion
Pharmaceutical giant Novartis is making a big purchase. The Swiss company is purchasing U.S. Endocyte…
October 18, 2018
Biotech & Pharma
Amgen Migraine Preventive Drug gets FDA Approval
The Food and Drug Administration has approved Amgen's drug Aimovig for the prevention of migraines.…
May 17, 2018
Hot Stocks
AT&T CEO Says it Was Mistake to Hire Trump’s Lawyer
AT&T Inc.'s CEO Randall Stephenson is regretting that it hired Michael Cohen, President Donald Trump's…
May 11, 2018
Biotech & Pharma
Novartis Just Made an $8.7 Billion Dollar Bet on this Gene Therapy Company
Novartis and AveXis shares saw big gains in Monday trading after it was announced that…
April 9, 2018
Biotech & Pharma
GlaxoSmithKline to Buy Novartis AG’s Stake in Consumer-Health Joint Venture for $13B
One of the biggest headlines in the healthcare arena on Tuesday was that GlaxoSmithKline Plc,…
March 27, 2018
Biotech & Pharma
Novartis to Buy This Big French Drug Maker for $3.9 Billion
Novartis AG announced on Monday that it will be acquiring Advanced Accelerator Applications, a French…
October 30, 2017
Biotech & Pharma
Novartis Climbs Higher After Earnings Rise
Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after…
October 24, 2017
Biotech & Pharma
Gilead Shares Move Higher After FDA Approves its Cancer Drug
Gilead made an excellent move acquiring Kite Pharma because a drug that Kite developed has…
October 19, 2017
Biotech & Pharma
Novartis AG CEO Resigns Suddenly
The CEO of Novarti AG has suddenly resigned. Chief Executive Officer Joseph Jimenez has been…
September 4, 2017